Dr. Dipender Gill, CEO and Founder of Sequoia Genetics will be speaking in a webinar on translational proteomics and large-scale mass spectrometry.
Key themes include:
• Expanding discovery through large-scale mass spectrometry
• Integrating genetics and proteomics for causal inference
• Improving robustness of target selection in drug development